Melasma-X Glutathione BrighteningTone Up Cream 45ml Features Enhancing Your Skins Radiance Achieving Instant Skin Tone Improvement Revitalizing Your Dehydrated Skin with Moisture Effective Wrinkle Care Remove Freckles, Pigmentation and Melasma Remove wrinkles, melasma, pigmentation, and freckles Moisturize your skin Repairing dark circles, pimples, and darkness Anti-aging Specifications Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging Net Weight: 45ml Brand: Melasma-X Product Line: Whitening Care Main Purpose: Wrinkle, melasma, pigmentation, dark circles, and freckles Product Line: Brightening Cream Formulation: Cream Type: Daily Use Body Area: Face Skin Type: All Skin Types Sun Protection Factor (SPF): SPF 0 Department: Unisex Period After Opening (PAO): 24M 100% Authentic Country/Region of Manufacture: Korea, Republic of Ingredients Aqua, Cyclomethicone, Glycenn, Methylpropanediol,Caprylic/Capric Glycerides, Cotyl Ethylhexanoate, Niacinamide Broussonetia Kazinoki Root Extract Morus Alba Root Extract Centella Anatica Extract, Sodium Hyaluronate Dimethicone,Zinc Oxide, Titanium Dioxide, Cyclopentasiloxane,Dimethicone/Vinyl Dimethicone Crosspolymer,Cetyl PEG/PPG-10/1 Dimethicone, Octyldodecanol, Sodium Chloride, Trehaloos Adenosin, Phenairyethanol Acetyl Hexapeptide-B,Disodium EDTA, Ceramide NP.Ceramide AP.Ceramide EOP Hydrolyzed Colleger, Glutathione (1,000ppm) Camellia Sinensis Leaf Extract Camellia Japonica Leaf Extract Schizandra Chinensis Fruit Extract, Portulaca Oleracea Extract, Plantago Asiatica Extract, Scutellaria Beicalensis Root Extract Paeonia Suffruticosa Root ExtractBrassica Oleracea Italica (Broccoli) Extract
Individual responses may vary
Supplementary Data 1) as well as Fzd1 , Map2 , Robo2 , Zic1 and Dll1 (Supplementary Fig
Inflammation 41 , 710721 (2018)
Based on some initial high-profile findings in gnotobiotic mice (Kolata, 2013) it was suggested that the GIT microbiome serve an important role in controlling feed intake, energy homeostasis and weight
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis
